Click here to go to the previous page
Navigating the Transition From Scientific to Clinical Communications
Program Code:
PUB060
Date:
Wednesday, May 9, 2007
Time:
11:00 AM to 12:30 PM
CHAIR
:
Cynthia Clayton, Director, Investor Relations and Corporate Communications, Alnylam
SPEAKER
:
Renee Connolly, Vice President, Corporate Communications, EMD Serono, Inc.
Description
This session will bring together some of the communications leaders and influencers in our industry to discuss the challenges and expectations for how companies communicate as they go from an early-stage science-focused company, to a more mature, clinical data-driven company.
Objectives:
Increase understanding of what the investment community looks for from a communications perspective as a science-driven company advances its pipeline into the clinic.
Gain an appreciation for how the business media value the spectrum of these types of communications from a biotech company.
Take away strategies and tactics to help implement a successful communications strategy as the company makes the transition to communicating clinical data.